Nanjing Haiwei Pharmaceutical Technologies was founded in April 2018. Haiwei ' mission is to accelerate therapeutic development with passion for life & sciences. Haiwei's expertise includes stabillity prediction, drug product design and development, pre-formulation, drug ability & developability assessment, pharamaceutical technologies for bioavailability enhancement. Haiwei has exciting combinational product pipelines of short-term, mid-term and long-term. Haiwei has established strategic collaboration with Freethink Technologies. Haiwei is currently the exclusive distributor for ASAPprime product and service provider in greater China region. Haiwei's longer-term product pipelines includes intellegent biopharamceutics, lab automation and super generics.